Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-03-04 @ 5:21 AM
Study NCT ID:
NCT03829020
Status:
COMPLETED
Last Update Posted:
2024-08-22
First Post:
2019-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-24
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-01
First Submit QC Date:
None
Study First Post Date:
2019-02-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-20
Last Update Post Date:
2024-08-22
Last Update Post Date Type:
ACTUAL